FI950229A0 - Tetracyclic compounds, processes and intermediates for their preparation and their use as antitumor agents - Google Patents

Tetracyclic compounds, processes and intermediates for their preparation and their use as antitumor agents

Info

Publication number
FI950229A0
FI950229A0 FI950229A FI950229A FI950229A0 FI 950229 A0 FI950229 A0 FI 950229A0 FI 950229 A FI950229 A FI 950229A FI 950229 A FI950229 A FI 950229A FI 950229 A0 FI950229 A0 FI 950229A0
Authority
FI
Finland
Prior art keywords
intermediates
processes
preparation
antitumor agents
tetracyclic compounds
Prior art date
Application number
FI950229A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI950229A (en
Inventor
Karl Witold Franzmann
Jeremy Nigel Stables
Patrick Vivian Richard Shannon
Nagaraja Kodanda Ranganath Rao
Laddawan Chunchatprasert
Original Assignee
Wellcome Found
Univ Cardiff
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found, Univ Cardiff filed Critical Wellcome Found
Publication of FI950229A0 publication Critical patent/FI950229A0/en
Publication of FI950229A publication Critical patent/FI950229A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/333Radicals substituted by oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56Ring systems containing three or more rings
    • C07D209/80[b, c]- or [b, d]-condensed
    • C07D209/94[b, c]- or [b, d]-condensed containing carbocyclic rings other than six-membered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI950229A 1992-07-20 1995-01-19 Tetracyclic compounds, processes and intermediates for their preparation and their use as antitumor agents FI950229A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215361A GB9215361D0 (en) 1992-07-20 1992-07-20 Heterocyclic compounds
PCT/GB1993/001512 WO1994002483A1 (en) 1992-07-20 1993-07-19 Tetracyclic compounds process and intermediates for their preparation and their use as antitumour agents

Publications (2)

Publication Number Publication Date
FI950229A0 true FI950229A0 (en) 1995-01-19
FI950229A FI950229A (en) 1995-03-10

Family

ID=10718981

Family Applications (1)

Application Number Title Priority Date Filing Date
FI950229A FI950229A (en) 1992-07-20 1995-01-19 Tetracyclic compounds, processes and intermediates for their preparation and their use as antitumor agents

Country Status (23)

Country Link
EP (1) EP0651750A1 (en)
JP (1) JPH08502037A (en)
KR (1) KR950702563A (en)
CN (1) CN1088209A (en)
AU (1) AU4579593A (en)
BG (1) BG99359A (en)
CA (1) CA2140662A1 (en)
CZ (1) CZ14995A3 (en)
FI (1) FI950229A (en)
GB (1) GB9215361D0 (en)
HR (1) HRP931066A2 (en)
HU (1) HUT76787A (en)
IL (1) IL106385A0 (en)
MX (1) MX9304355A (en)
NO (1) NO950202D0 (en)
NZ (1) NZ254207A (en)
PL (1) PL307169A1 (en)
RU (1) RU95104939A (en)
SI (1) SI9300390A (en)
SK (1) SK7595A3 (en)
WO (1) WO1994002483A1 (en)
YU (1) YU50293A (en)
ZA (1) ZA935213B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9401921D0 (en) * 1994-02-01 1994-03-30 Wellcome Found Heterocyclic compounds
GB9413758D0 (en) * 1994-07-07 1994-08-24 Wellcome Found Heterocyclic compounds
GB9804343D0 (en) * 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
US7419992B2 (en) 2001-02-14 2008-09-02 Wisconsin Alumni Research Foundation Use of aryl hydrocarbon receptor ligand as a therapeutic intervention in angiogenesis-implicated disorders
DE60232403D1 (en) * 2001-02-14 2009-07-02 Wisconsin Alumni Res Found PREPARATIONS AND USE OF AN AH RECEPTOR LIGAND, 2- (1'H-INDOL-3'-CARBONYL) -THIAZOL-4-CARBOXYLIC ACID METHYL ESTER
GB0302094D0 (en) 2003-01-29 2003-02-26 Pharmagene Lab Ltd EP4 receptor antagonists
GB0324269D0 (en) 2003-10-16 2003-11-19 Pharmagene Lab Ltd EP4 receptor antagonists
US20100130579A1 (en) * 2006-10-23 2010-05-27 Georgetown University Cancer therapy
BRPI0917411A2 (en) 2008-08-15 2015-12-01 Univ Georgetown dansyl carbazole compound, method for treating cancer in a subject, method for reducing dna menthyltransferase activity in a cell, method for increasing expression of family domain 1a (rassf1a) association in a cell, cell identification methods Method of determining whether one or more cells of a subject are cancer cells, pharmaceutical composition and kit.
JP2012051804A (en) * 2008-12-26 2012-03-15 Kyoto Univ Eg5 INHIBITOR
KR20160066490A (en) 2014-12-02 2016-06-10 주식회사 씨앤드씨신약연구소 Heterocyclic derivatives and use thereof
US11053255B2 (en) 2015-06-22 2021-07-06 Georgetown University Synthesis of mahanine and related compounds
CN109776550B (en) * 2019-01-17 2021-08-10 广东轻工职业技术学院 Alkaloid compound derived from marine fungi and application thereof in preparation of food preservative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0300688A1 (en) * 1987-07-21 1989-01-25 FISONS plc Pyrrole derivatives, process for their preparation and pharmaceutical compositions containing them
US5166204A (en) * 1989-11-01 1992-11-24 Toyama Chemical Co., Ltd. Isoindole derivatives and salts thereof and antitumor agent comprising the same
WO1991014688A1 (en) * 1990-03-20 1991-10-03 The Wellcome Foundation Limited Hetero polycyclic biocidal compounds and their use in medecine

Also Published As

Publication number Publication date
NZ254207A (en) 1997-03-24
WO1994002483A1 (en) 1994-02-03
FI950229A (en) 1995-03-10
YU50293A (en) 1997-01-08
CN1088209A (en) 1994-06-22
KR950702563A (en) 1995-07-29
NO950202L (en) 1995-01-19
ZA935213B (en) 1995-01-19
MX9304355A (en) 1994-04-29
JPH08502037A (en) 1996-03-05
HUT76787A (en) 1997-11-28
AU4579593A (en) 1994-02-14
PL307169A1 (en) 1995-05-15
CA2140662A1 (en) 1994-02-03
HU9500171D0 (en) 1995-03-28
RU95104939A (en) 1996-10-27
GB9215361D0 (en) 1992-09-02
IL106385A0 (en) 1993-11-15
EP0651750A1 (en) 1995-05-10
SI9300390A (en) 1994-03-31
SK7595A3 (en) 1995-07-11
CZ14995A3 (en) 1995-10-18
BG99359A (en) 1995-11-30
NO950202D0 (en) 1995-01-19
HRP931066A2 (en) 1995-12-31

Similar Documents

Publication Publication Date Title
FI963283A (en) 4-heterocyclyl-substituted quinazoline derivatives, processes for their preparation and their use as cancer drugs
FI934220A (en) Piperidinderivat, framstaellning daerav och avaendning daerav vid en terapi
FI934373A (en) FABRIKATIONSPROCESS AV KOMPOSITTRAOD OCH KOMPOSITPRODUKTER SOM FAOTTS AVNAEMNDA TRAODEN
FI930620A0 (en) BENSIMIDAZOLYLDERIVAT, DESSA FOERENINGAR INNEHAOLLANDE LAEKEMEDEL OCH FOERFARANDE FOER DERAS FRAMSTAELLNING
FI945662A0 (en) Roerformad stomme, i synnerhet som sleselement och med medselselement foersedd stomme
FI950229A (en) Tetracyclic compounds, processes and intermediates for their preparation and their use as antitumor agents
FI103666B1 (en) Process for the preparation of biphenyl derivatives
FI932625A0 (en) Anordning och foerfarande Foer detektering av ytfel i laonga, i roerelse befintliga metallprodukter
FI931291A0 (en) INDOL- OCH INDAZOLDERIVAT FOER BEHANDLING OCH FOEREBYGGANDE AV HJAERNSJUKDOMAR, DERAS FRAMSTAELLNING OCH ANVAENDNING
FI935829A0 (en) Anlaeggning och foerfarande Foer uttnyttjning av braennbara aemnen, speciellt industri- ocus hushaollsavfall
FI923855A (en) Catalyst and preparation process for the same
FI934221A (en) Piperidinderivat, framstaellning och therapeutisk anvaendning daerav
FI931682A (en) TACKYKININRECEPTORANTAGONISTER, ISOKINOLONER OCH DERAS FRAMSTAELLNING
FI950874A0 (en) New polyiodized compounds, process for their preparation and those containing contrast agents
FI932750A0 (en) Kaoda nedbrytande svampar och preparation av dem
FI935196A0 (en) Pyrrolderivat, framstaellning av dem och anvaendning av dem vid terapi
FI935132A (en) FENOLISK RESOLFANERHARTS, FOERFARANDE OCH TILLVERKNING
FI875704A (en) OVER MASKIN OVER MASKING FOR SKALNING AV LOCATION.
FI931159A (en) DISPENSER, SOM INNEHAOLLER SOM AKTIVT AEMNE FLEZELASTIN OCH MED DETTARELATERADE STRUKTURER
FI950101A0 (en) 4-Oxa-1-azabicyclo 3,2,0 -7heptanone derivatives as antitumor agents
FI934164A0 (en) ANORDNING FOER ATT UTFOERA MIG-SVETSNING PAO EN TREDIMENSIONELL KURVAD YTA, OCH EN SVARVANORDNING FOER AUTOMATISK FORMNING AV SVETSSKAOROR
FI924350A0 (en) CONSTRUCTION CONSTRUCTION FOR AVERAGE AVGAS OCH FOERFARANDE FOER FRAMSTAELLNING AV DENNA.
FI806U1 (en) Combination of eldstad, roeklaeda och stekunderlag
FI48U1 (en) Anordning Foer ljus, vaser och dylika
NO950061D0 (en) 4-oxa-1-azabicyclo [3.2.0Å heptan-7-one derivatives as antitumor agents